The rising prevalence of lifestyle diseases such as diabetes, cardiovascular diseases, and obesity significantly drives the men's health market in the UAE and Saudi Arabia by increasing the demand for healthcare services tailored to men's specific health issues. According to the latest figures from SEHA, men in the U.A.E. are not doing enough to take charge of their health. 70 percent of Emirati men under the age of 30 years are known to suffer from obesity and diabetes. Not enough men between 20 to 30 years of age are undergoing regular full physical work-ups, and screening for prevalent health issues. As these lifestyle-related conditions become more common, there is a corresponding rise in the need for both preventive and curative healthcare measures. Men in these regions are unaware about health consciousness and are did not likely to seek regular health check-ups, screenings, and lifestyle consultations, which has led to a greater emphasis on preventive healthcare. This shift towards preventive measures has also spurred growth in the wellness and fitness industries, as men increasingly look for ways to maintain a healthy lifestyle and mitigate the risks associated with these chronic diseases.
Access Full Report @ https://www.databridgemarketresearch.com/pt/reports/uae-and-saudi-arabia-mens-health-market
Data Bridge Market Research analyzes that the U.A.E. and Saudi Arabia Men’s Health Market is growing with a CAGR of 12.4% in the forecast period of 2024 to 2031 and is expected to reach USD 822.16 million by 2031 from USD 334.55 million in 2023.
Key Findings of the Study
Increase Incidence Rate of Infertility in Men
The increasing incidence rate of infertility in men acts as a significant driver in the U.A.E. and Saudi Arabia men's health market by boosting the demand for a wide range of medical services and treatments. A cross-sectional sample of patients seeking fertility treatment in a major fertility clinic in Abu Dhabi, U.A.E. was surveyed from April to May 2021 and result shows that out of the 42 infertile males, 69.0% had an abnormal semen analysis. As infertility becomes a more prevalent concern, this leads to greater utilization of diagnostic services, including semen analysis, hormonal testing, and genetic evaluations, which necessitates the establishment and expansion of specialized fertility clinics and laboratories. The growing need for effective treatment options, such as medication, surgical interventions, and assisted reproductive technologies like IVF and ICSI, drives investments in advanced reproductive technologies and specialized healthcare providers. Also, increased awareness and education about infertility issues prompt men to seek medical advice and treatment, all of which enhance the availability, quality of infertility treatments and related healthcare services, contributing to the overall growth of the men’s health market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Type (Treatment and Diagnosis), Disease Type (Male Erectile Dysfunction, prostate cancer, Male Hypogonadism and Male Urinary Incontinence), Age Group (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Home Healthcare and Others)
|
|
Countries Covered
|
U.A.E. and Saudi Arabia
|
|
Market Players Covered
|
Cardinal Health (Europe), Pfizer Inc. (U.S.), Astellas Pharma Inc. (Japan), Lilly (U.S.), Coloplast Corp. (Europe), AbbVie Inc. (U.S.), Novartis AG (Switzerland), and Boston Scientific Corporation (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis
U.A.E. and Saudi Arabia men's health market is categorized into four notable segments which are based on the type, disease type, age group and end user.
- Based on type, U.A.E. and Saudi Arabia men's health market is segmented into treatment and diagnosis
In 2024, the treatment segment is expected to dominate the U.A.E. and Saudi Arabia men's health market
In 2024, treatment segment in U.A.E. is expected to dominate the market with 70.19% market share and Saudi Arabia is expected to dominate the market with 67.51% market share due to high prevalence of health conditions like erectile dysfunction and prostate issues, coupled with advancements in medical technology that offer effective treatment options, driving demand for therapeutic interventions.
- Based on disease type, the U.A.E. and Saudi Arabia men’s health market is segmented into male erectile dysfunction, prostate cancer, male hypogonadism and male urinary incontinence
In 2024, the male erectile dysfunction segment is expected to dominate the U.A.E. and Saudi Arabia men’s health market
In 2024, male erectile dysfunction segment in U.A.E. is expected to dominate the market with 42.39% market share and Saudi Arabia is expected to dominate the market with 45.82% market share due to its high prevalence among men in these countries, increasing awareness, and the availability of effective treatments including medications and implants, driving significant demand for solutions in this segment.
- Based on age group, U.A.E. and Saudi Arabia men’s health market is segmented into geriatric, adult and pediatric. In 2024, geriatric segment in U.A.E. is expected to dominate the market with 46.79% market share and Saudi Arabia is expected to dominate the market with 45.47% market share
- Based on end user, U.A.E. and Saudi Arabia men’s health market is segmented into hospitals, specialty clinics, home healthcare and others. In 2024, hospitals segment in U.A.E. is expected to dominate the market with 41.36% market share and Saudi Arabia is expected to dominate the market with 48.82% market share
Major Players
Data Bridge Market Research recognizes the following companies as the major market players in the U.A.E. and Saudi Arabia men’s health market are Cardinal Health (Europe), Pfizer Inc. (U.S.), and Astellas Pharma Inc. (Japan) among others.
Market Developments
- In January 2024, Cardinal Health to acquire Specialty Networks and its PPS Analytics platform a technology enabled multi-specialty group purchasing and practice enhancement organization
- In June 2023, Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization
- In November 2019, Pfizer, Inc. announced that its division named Upjohn is combined with Mylan N.V. and formed a new company named Viatris. This combination of the company's business division with Mylan N.V. has increased its product portfolio, leading to increased demand for its product in the market
- In November 2019, Pfizer, Inc. announced that its division named Upjohn is combined with Mylan N.V. and formed a new company named Viatris. This combination of the company's business division with Mylan N.V. has increased its product portfolio, leading to increased demand for its product in the market
- In January 2023, Coloplast appoints new president of its global Interventional Urology business. Mentioned, guiding the IU business into the future, where they will reach an increasing number of clients worldwide with both new and current goods and solutions. They are a growth company with a mission, as well as a fantastic place to work
For more detailed information about the U.A.E. and Saudi Arabia men’s health market report, click here – https://www.databridgemarketresearch.com/pt/reports/uae-and-saudi-arabia-mens-health-market
